Format

Send to

Choose Destination
Z Gerontol Geriatr. 2018 Feb;51(2):143-148. doi: 10.1007/s00391-017-1351-y. Epub 2017 Dec 5.

[Doping for the brain].

[Article in German]

Author information

1
Christian-Doppler-Klinik, Universitätsklinik für Geriatrie der PMU, Uniklinikum Salzburg, Ignaz-Harrer-Str. 79, 5020, Salzburg, Österreich. b.iglseder@salk.at.

Abstract

The enhancement of physical and cognitive abilities (i. e. concentration, vigilance, memory) has always been desirable for humans. The term pharmacological neuroenhancement refers to the use of legal or nonprescription psychoactive substances by healthy subjects with the intention of cognitive enhancement. To give the most prominent example, caffeine serves worldwide as a natural stimulant. Brain doping, however, specifies the use of illegal substances or prescription drugs beyond approval with the purpose of cognitive enhancement. Only amphetamines, methylphenidate and modafinil have significant effects on attentiveness, concentration and alertness, whereas other substances, such as anti-dementia drugs or anti-depressants failed to demonstrate cognitive enhancement in healthy subjects.

KEYWORDS:

Brain doping; Cognition; Enhancement; Neuroenhancement; Psychotropic drugs

PMID:
29209802
DOI:
10.1007/s00391-017-1351-y

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center